2024 HCPCS Code G9090
Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
TAGS: adenocarcinoma initially invasive disease demonstration limited rectal evidence predominant extent metastases established
| Short Description | Onc dx rectal t1-2 no progr |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Code Added Date | January 01, 2006 |
| HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- G1019 - Cdsm logicnets
- G1020 - Cdsm curbside
- G1021 - Cdsm ehealthline
- G1022 - Cdsm intermountain
- G1023 - Cdsm persivia
- G1024 - Cdsm radrite
- G1025 - Pt mnth 1 mcp prov
- G1026 - Pt hemo > 3mo
- G1027 - Pt hemo < 3mo
- G1028 - Take home supply 8mg per 0.1
- G2000 - Blinded conv. tx mdd clin tr
- G2001 - Post d/c h vst new pt 20 m
- G2002 - Post-d/c h vst new pt 30 m
- G2003 - Post-d/c h vst new pt 45 m
- G2004 - Post-d/c h vst new pt 60 m
- G2005 - Post-d/c h vst new pt 75 m
- G2006 - Post-d/c h vst ext pt 20 m
- G2007 - Post-d/c h vst ext pt 30 m
- G2008 - Post-d/c h vst ext pt 45 m
- G2009 - Post-d/c h vst ext pt 60 m